Noticias de Eulerpool Nxera Pharma Co

Nxera Pharma Co Noticias de Acciones

Nxera Pharma Co es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Nxera Pharma Co.

• 3 de junio ·

  Yahoo
  Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of NBI-1117568
• 2 de mayo ·

  Yahoo
  Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025
• 1 de mayo ·

  Yahoo
  Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia
• 28 de febrero ·

  Yahoo
  Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris
• 14 de febrero ·

  Yahoo
  Nxera Pharma Proposes Changes to its Board of Directors
• 14 de febrero ·

  Yahoo
  Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2024
• 20 de diciembre ·

  Yahoo
  Nxera Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
• 19 de diciembre ·

  Yahoo
  Nxera Pharma and Shionogi Launch QUVIVIQ™ in Japan for Adults with Insomnia
• 5 de noviembre ·

  Yahoo
  Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI
• 1 de noviembre ·

  Yahoo
  Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2024